E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/31/2006 in the Prospect News Biotech Daily.

LCA Vision reiterated at market outperform by JMP

JMP Securities analyst Anthony Ostrea reiterated LCA Vision Inc. at market perform and $64 price target. According to the analyst, the company differs from others in the market since it is growing organically 20%-plus in a flat to slightly down market. In addition, LCA has the cash flow to expand its center base by another 67 centers in the United States. Shares of the Cincinnati-based laser vision correction services company were up 33 cents, or 0.77%, at $43.15 on volume of 766,119 shares versus the three-month running average of 523,988 shares. (Nasdaq: LCAV)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.